Introduction: The positive-to-resected lymph node ratio (LNR) predicts survival in many cancers, but little information is available on its value for patients with N2 NSCLC who receive postoperative radiotherapy (PORT) after resection. We tested the applicability of prognostic scoring models and heat mapping to predict overall survival (OS) and cancer-specific survival (CSS) in patients with resected N2 NSCLC and PORT.
Introduction
NSCLC accounts for nearly 85% of all cases of lung cancer. 1 In patients with node-positive NSCLC, the risk of locoregional recurrence is as high as 20% to 40%. 2 With an LNR of 0.31 or higher, patients might have poor outcomes needing close follow-up while taking into consideration of other clinically significant factors in the prognostic scoring model, 3 even though postoperative radiotherapy (PORT) was found to be detrimental to survival in a meta-analysis of studies conducted about three decades ago. 4 However, the benefit of PORT remains controversial for patients with N2 NSCLC because *Corresponding author.
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analyses of relevant randomized controlled trials are still ongoing. 5 Further, few reports have focused on how to identify patients with N2 NSCLC who might derive the greatest (or least) benefit from PORT in terms of overall survival (OS) or cancer-specific survival (CSS). 3 Nodal assessment is one way to evaluate the survival outcome of patients who have received PORT. 6 The lymph node ratio (LNR), which is defined as the ratio of positive lymph nodes (LNs) to the total number of LNs examined, has been shown in a few studies to be related to survival outcomes in patients with NSCLC who are receiving PORT. 3 However, most such studies of LNR were single-institution analyses with small numbers of patients and a variety of cutoff points. 3 To fill this gap, we sought to identify the potential significance of LNR in assessing survival outcomes in patients with resected N2 NSCLC who underwent PORT. To do so, we constructed heat maps to provide evaluate detailed linkages of different combinations of numbers of positive and negative LNs. We further sought to develop and externally validate a prognostic scoring model for such patients.
Methods

Database and Cohort Definition
For the database and cohort definition, see Supplementary Data 1.
Statistical Analysis
Categorical variables were compared by using the chi-square test. Recursive partitioning analysis was used to identify optimal cutoff points for the LNR (see Supplementary Data 2 for further details ). 7 A cutoff value of 10 for the total number of resected LNs was chosen on the basis of previous publications. 8 Simple prognostic scoring systems were developed on the basis of significant factors acquired from the multivariate analysis. The scores were the weighted sums of the factors, in which the weights were defined as the quotient of the corresponding estimated coefficient divided by the smallest chi-square coefficient. 9 Heat maps were created to visualize the distribution of numbers of positive and negative LNs with the corresponding survival probabilities obtained from the regression models. 10 All statistical tests were two sided.
Results
Patient Characteristics
Clinicopathologic information on the patients in the Surveillance, Epidemiology, and End Results (SEER) and validation cohorts is provided in Table 1 . In the SEER group, the median patient age was 64 years (range 19-90). Of the total 2329 patients in the SEER group, 51.4% (1182) were younger than 65 years and 49.2% (1147) were at 65 years old. In the validation group, the median patient age was 64 years, and 44.3% of patients (81) were men. The median number of resected positive nodes was 3 (range 1-61) in the SEER group and 3 (range 1-25) in the validation group. Compared with the SEER group, the validation group included fewer patients with poorly differentiated tumors. No differences were observed among any of the other clinicopathologic variables (age, sex, type of surgery, chemotherapy, laterality, histologic type, and tumor stage) between the two groups.
LNR Cutoff and Kaplan-Meier Survival Estimates
In the training group, the median follow-up time was 23 months and the OS rates at 1, 3, and 5 years were 58%, 34%, and 24%, respectively. In the validation group, the median follow-up time was 48 months, and the 1-, 3-, and 5-year OS rates were 78%, 62%, and 48%, respectively. Recursive partitioning analysis identified 0.31 as being the optimal cutoff point for LNR for assessing survival in the training group; patients with an LNR less than 0.31 had better OS and CSS rates than did patients with an LNR of 0.31 or higher in both the training and validation groups (all log-rank p < 0.05) (Fig. 1) . 
Univariate and Multivariate Analysis in the Training Cohort
For OS, all of these factors except for type of surgery and total number of resected LNs retained independent associations with OS in multivariate analysis in the SEER group (Table 2) . For CSS, univariate analysis showed age, sex, type of surgery, receipt of chemotherapy, tumor histologic type and grade, total number of LNs resected, and LNR to be correlated with CSS (Table 3) . Age, receipt of chemotherapy, tumor category, tumor grade, and LNR retained independent associations with CSS in multivariate analysis (see Table 3 ).
Prognostic Scoring Model
Next, the relative contributions of the variables to the risk scores in the Cox regression models were assessed in terms of their chi-square scores (see Tables 2 and 3 ). For the SEER data set, using the median value of 9.8 as a cutoff point distinguished two risk groups in terms of OS: low-risk (<9.8) and high-risk (9.8). The 1114 lowrisk patients had significantly better OS than did the 1132 high-risk patients (p < 0.001) (Fig. 2A) . Use of the same cutoff point for OS in the validation data set also distinguished the low-risk patients from the high-risk patients (Fig. 2C) . As for CSS, using a cutoff point of 9.6 (the median chi-square score) led to the whole patient group being subdivided into either low-risk (<9.6) or high-risk ( 9.6) patients. The CSS was also significantly better in the low-risk subgroup than in the high-risk subgroup (P < 0.001) (Fig. 2B) . These prognostic scoring models also were able to distinguish the low-risk subgroup from the high-risk subgroup in the validation data set (Fig. 2D) .
Heat Maps Based on the Survival Models
Heat maps were created to observe the association of combination of positive and negative LNs with survival on the basis of the survival models (Fig. 3) . Survival probabilities were obtained from the multivariate models. The maps visualize how differences in the positive LN and negative LN counts correlated with 3-year, 5-year, and 10-year survival. Regions in red indicate relatively better survival outcomes compared with regions in blue.
Discussion
In this study, we developed prognostic scoring models and corresponding heat maps to predict survival outcomes for patients with resected pN2 NSCLC who also received PORT. In both the training and validation cohorts, patients with low LNR values were more likely to have better survival outcomes. Major American professional societies have published guidelines regarding surveillance for patients after curative surgery for lung cancer. 11 Given the acknowledged costs and risks resulting from radiation exposure, our prognostic scoring model has potential clinical implications in that the model is feasible, is easy to apply, and may help to identify patients at high risk of poor outcomes. The LNR is well known for its ability to predict survival in many types of cancer; however, few reports have explored the use of LNR in patients with resected pN2 NSCLC who also received PORT. 3 Moreover, until now no easy-to-apply prognostic scoring model had been available to help guide the prognosis. Several clinical scoring systems that include clinical and laboratory variables for use in predicting cancer survival have been developed. Wong et al. 12 developed a simple clinical prognostic scoring model for use in predicting the development of hepatocellular carcinoma in carriers of chronic hepatitis B; the test set of 1005 patients and the validation set of 424 patients both showed the feasibility of this approach. Another similar approach was used by Xi et al. to identify patients with esophageal cancer who are likely to benefit from induction chemotherapy before neoadjuvant chemoradiotherapy; the risk scores that were derived successfully distinguished patients as low-risk or high-risk. 9 In the current study, we created prognostic scoring models with the goal of determining which subgroup of patients among those with resected N2 NSCLC after PORT would have better survival outcomes. With an LNR of 0.31 or higher, patients might have poor outcomes requiring close follow-up while taking into consideration other clinically significant factors in the prognostic scoring model.
Strengths of this study include the following. First, by using a detailed heat-mapping method, we were able to identify how the number of positive and negative LNs correlated with survival. As Figure 3 illustrates, the segregation in distribution of number positive and negative LNs and survival is easily visualized with this method. Heat maps and the associated analytical methods offer a new way of understanding how LN status correlates with outcomes in patients with NSCLC. To our knowledge, this is the first study to use a heat map approach to investigate LNs and survival outcomes. Second, this is the first study to explore the efficacy of LNR for predicting survival in patients with NSCLC in which the optimal cutoff point was identified by recursive partitioning. Third, we used an external validation data set.
The major limitation of this study is its retrospective nature. Also, the SEER database contains no information about chemoradiotherapy, metastatic LN stations, and some other factors that can influence the results from PORT.
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Conclusion
In conclusion, a low LNR was associated with improved OS and CSS for patients with resected N2 NSCLC who also received PORT. Our innovative use of heat mapping to visualize prognosis based on the number of resected LNs and application of simple prognostic scoring models could facilitate the implementation of such models in routine clinical use.
